| KILITCH Stock | | | 310.65 3.25 1.06% |
Kilitch Drugs financial indicator trend analysis is infinitely more than just investigating Kilitch Drugs Limited recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kilitch Drugs Limited is a good investment. Please check the relationship between Kilitch Drugs Cost Of Revenue and its Operating Income accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kilitch Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
Cost Of Revenue vs Operating Income
Cost Of Revenue vs Operating Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Kilitch Drugs Limited Cost Of Revenue account and
Operating Income. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Kilitch Drugs' Cost Of Revenue and Operating Income is 0.57. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Operating Income in the same time period over historical financial statements of Kilitch Drugs Limited, assuming nothing else is changed. The correlation between historical values of Kilitch Drugs' Cost Of Revenue and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Kilitch Drugs Limited are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Cost Of Revenue i.e., Kilitch Drugs' Cost Of Revenue and Operating Income go up and down completely randomly.
Correlation Coefficient | 0.57 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Cost Of Revenue
Cost of Revenue is found on Kilitch Drugs Limited income statement and represents the costs associated with goods and services Kilitch Drugs provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Operating Income
Operating Income is the amount of profit realized from Kilitch Drugs Limited operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Kilitch Drugs Limited is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Most indicators from Kilitch Drugs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kilitch Drugs Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kilitch Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
As of now, Kilitch Drugs'
Tax Provision is increasing as compared to previous years. The Kilitch Drugs' current
Issuance Of Capital Stock is estimated to increase to about 40.5
M, while
Selling General Administrative is projected to decrease to under 25
M.
Kilitch Drugs fundamental ratios Correlations
Click cells to compare fundamentals
Kilitch Drugs Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Kilitch Drugs fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Kilitch Stock
Balance Sheet is a snapshot of the
financial position of Kilitch Drugs Limited at a specified time, usually calculated after every quarter, six months, or one year. Kilitch Drugs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Kilitch Drugs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Kilitch currently owns. An asset can also be divided into two categories, current and non-current.